U.S. Cannabis Market Is Booming, Curaleaf Chairman Says

Tilray CEO Sees Canada Profit in the 'Next Quarter or Two'

Cannabis company Tilray beats revenue expectations but reports adjusted ...

Buy Biogen on the dip? What about AMC on the streaming wars? The viewers...

Albert Technologies reports near three-fold increase in 2018 revenues

Nuformix Plc kicks off clinical trial for its chemo side effect drug

CytoDyn more than doubles recovery rate in its monotherapy HIV trial

Summit Therapeutics advancing its pipeline of innovative antibiotics

Dyadic International CEO reflects on 2018 accomplishments and reveals ye...

Humanigen's new data show increase in mice survival with lenzilumab

StemoniX is a very unique company making human microorgans from skin

Anatara Lifesciences transitions gut health focus from animals to humans

Update with Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC) - February 201...

Sharps Provensa: New Smart Safety Syringe from Sharps Technology

CEL-SCI Corp (NYSE:CVM) CEO on Successful Immunotherapy Cancer Treatment...

Imugene will present lead candidate HER-Vaxx at AACR Annual Meeting

Arcadia Biosciences Inc gets into the cannabis game leveraging its wheat...

Barron's Andrew Bary breaks down his top biotech bets

CEORoadshow Interview with Todd Davis, Chairman & CEO of CBD Unlimited, ...

Ingesting Instead of Inhaling Could Save 60,000 Lives a Year - Lexaria B...

Ascletis Pharma Inc. (HKEX: 1672) | Stock News Now

Carmell Therapeutics Corporation (Private Company) | Stock News Now

Curis, Inc. (NASDAQ: CRIS) | Stock News Now

Strainprint Technologies Ltd is a Data Analytics Platform Revolutionizin...

DNA Genetics Co Founder Don Morrison Discusses Cannabis Genes with 48No...

Imugene presenting all three immuno-oncology programs at AACR Annual Mee...

Shield Therapeutics CEO hails positive head-to-head Feraccru study results

Ocutrx Vision Technologies looks to treat blindness with augmented reali...

FDA accepted CytoDyn’s request and plan to submit BLA on rolling basis

IXICO PLC to support late phase clinical research programme in Huntingto...

Allergy Therapeutics celebrating 20 years of growth and innovation

Seelos Therapeutics shares soar on acquisition of Parkinson's candidate ...

CytoDyn presents 'stunning' data on treatment of HIV at Seattle conference

CytoDyn's HIV drug leromlimab takes a big step forward

OptiBiotix Health chief outlines critical new SlimBiome distribution deal

Yourgene Health 'presses the reset button' as it ramps up its internatio...

Admedus CEO in New York to update on recent key milestones

Q BioMed licenses significant biomarker to diagnose glaucoma

Arix Bioscience acquires stake in novel firm developing sickle cell trea...